The UK is set to donate a surplus of 100 million anti-Govit-19 vaccines, of which 25 million will be announced by British Prime Minister Boris Johnson on Friday, coinciding with the launch of the G7 summit by the end of 2021.
The news comes on the day the White House confirmed that the United States will buy 500 million doses of Pfizer vaccine to be distributed to 92 underdeveloped countries, of which 200 million by the end of the year and the rest in the first half of 2022.
Last week, Johnson called on other G7 leaders to help vaccinate by the end of 2022, hoping the summit would pledge to provide at least a billion dollars, either through surplus donations or funding.
The UK plans to deliver the first batch of five million doses by the end of September, when it is expected that all adults in the UK will be vaccinated and children will be vaccinated.
According to a report, the World Health Organization (WHO) -led initiative aimed at ensuring vaccinations for low- and middle-income countries will go 80 million doses to Kovacs, and the rest will be shared bilaterally.
“As a result of the success of the UK vaccination program, we are now in a position to share our overdose with those in need. In doing so, we will take a big step in defeating this epidemic forever,” he said, urging other leaders to make similar promises.
In total, the UK has ordered 517 million doses of different vaccines for a population of about 66 million, but he argues that boosters need adequate vaccines or respond to new types.
In the United Kingdom, the United States and the European Union more than 50% of the population is already vaccinated with a single dose, but only 2% of the population on the African continent is vaccinated and the world average is 12%.
The G7 Summit in Cornwall, in the southwest, will discuss ways to increase vaccine production and distribution capacity globally with pharmacists.
US President Joe Biden has suggested suspending the patent, but the proposal has met with opposition from other G7 leaders, with European Council President Charles Michael arguing that it is not the solution.
“We would like to focus on concrete projects such as promoting voluntary licensing and changing knowledge and sharing patents in mutually agreed terms,” he said before attending the meeting in Brussels.
The British government has invested millions of pounds to develop a vaccine by the University of Oxford and the Astrogeneca Laboratory.
Following that, Pfizer, Moderna and Johnson & Johnson also pledged to share the $ 1.3 billion dose with developing countries.
The G7 summit takes place on Fridays and Sundays, for the first time in two years by G7 leaders (Germany, Canada, the United States, France, Italy, Japan and the United Kingdom) and the European Union.